← All trials
NCT04905667
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 13, 2019
- Primary completion
- Sep 8, 2020
- Completion date
- Sep 11, 2020
- First posted
- May 27, 2021
- Last posted
- May 27, 2021
- Enrollment
- 87
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Genor BioPharma Co., Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.